To evaluate whether PEF-5 could also change the balance between stemness and differentiation in GBM cells, we evaluated the expression of stemness (CD133 and CD15) and differentiation (β-III TUBULIN) markers. The gene discussed is PROM1; the disease is glioblastoma.